The silencing of CD99 was shown to inhibit the growth and migration of Ewing sarcoma cells (Kreppel et al., 2006) or to induce neural differentiation in Ewing sarcoma cells and reduce their tumorigenicity and bone metastasis capability (Rocchi et al., 2010). The gene discussed is CD99; the disease is Ewing sarcoma.